Well Told Grants

Grants / Department of Health and Human Services / Centers for Disease Control and Prevention - ERA

RFA-TS-25-036: Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS)

Closed Closed November 4, 2024 Opportunity RFA-TS-25-036

This grant is closed. A newer notice from the same program is forecast: Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS) (RFA-TS-27-018). Status: Expected deadline February 1, 2027. It is in our archive of Centers for Disease Control and Prevention - ERA notices from 2024.

Centers for Disease Control and Prevention - ERA offered grants of up to $500,000 to any type of organization. It expected to make about 8 awards worth $7.5 million in total. Applications closed on November 4, 2024.

From the official notice on Grants.gov, last changed October 9, 2024. Checked November 7, 2026.

Other notices with this title

Centers for Disease Control and Prevention - ERA has posted this title under other numbers: earlier or later rounds, or the same competition for another area. Each has its own dates and may change its rules.

NoticePostedDeadlineStatus
RFA-TS-27-018July 8, 2026Expected deadline February 1, 2027Forecast
RFA-TS-26-165May 11, 2026Closed June 10, 2026Closed
RFA-TS-24-010August 1, 2023Closed December 19, 2023Closed
RFA-TS-23-001September 30, 2022Closed January 5, 2023Closed
RFA-TS-22-001February 14, 2022Closed April 22, 2022Closed
RFA-TS-21-001January 8, 2021Closed March 29, 2021Closed

Key dates

PostedAugust 1, 2024
DeadlineNovember 4, 2024
Archived by Grants.govMarch 9, 2025

Who can apply

This opportunity was open to any type of organization.

All 14 applicant types the notice lists

See Section III. Eligibility Information.

More grants for nonprofits, colleges and universities, state and local governments, tribes, small businesses, businesses, individuals.

Is this a realistic fit?

What the grant funds

The Centers for Disease Control/Agency for Toxic Substances and Disease Registry (CDC/ATSDR) is seeking investigator-initiated research that will identify and evaluate potential risk factors contributing to Amyotrophic Lateral Sclerosis (ALS), with preferred focus on research proposals that will examine factors related to military service, contact sports, traumatic brain injury, neuroinflammation, and infectious agents. Research proposals on preferred topics can be funded under one of three funding options, Funding Option A, Funding Option B, or Funding Option C. Funding Option A is intended to support ALS risk factor research investigations that have an existing, well substantiated evidence base and would benefit from strengthened rigorous evaluation. Funding Option B is intended to support novel ALS risk factor research investigations that may or may not have an existing evidence base, may be supported by limited and insufficient preliminary research, and are exploratory and developmental in nature. Funding Option C is intended to support research and better understanding of ALS risk including prevalence and incidence in communities such as racial and ethnic minority populations (e.g., Black or African American persons, Hispanic or Latino persons, Asian persons) and military veterans.

Category: Health.

Who has won Innovations in Applied Public Health Research grants before

From fiscal 2021 to 2025, Innovations in Applied Public Health Research (93.061) awarded $3.9 million across 7 grant awards, an average of $557,604 per award.

Largest recipients, fiscal 2021 to 2025
RecipientStateAwardsAmount
President and Fellows of Harvard CollegeMassachusetts2$2.0 million
Firebird Biomolecular Sciences LLCFlorida1$972,101
Regents of the University of MichiganMichigan1$500,000
Als Therapy Development FNDMassachusetts1$480,595
Northwestern UniversityIllinois1$299,999

Top states: Massachusetts ($2.5 million), Florida ($972,101), Michigan ($500,000), Illinois ($299,999), Pennsylvania ($16,236).

Applying now

This notice no longer takes applications. Apply under the newer notice, RFA-TS-27-018, which is forecast.

The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.

Questions people ask

Is RFA-TS-25-036 still open?

No. It closed on November 4, 2024. A newer notice is forecast: RFA-TS-27-018, expected deadline February 1, 2027.

Who can apply for Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS)?

Centers for Disease Control and Prevention - ERA accepted applications from any type of organization. The notice adds further conditions, so read its eligibility section.

What is the deadline for Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS)?

Closed November 4, 2024. Applications are no longer accepted; the program's newer notices are on this page when there are any.

How much funding is available?

Awards of up to $500,000 each. About $7.5 million in total across about 8 awards.

Who has won Innovations in Applied Public Health Research grants before?

The largest recipients over five fiscal years were President and Fellows of Harvard College, Firebird Biomolecular Sciences LLC, Regents of the University of Michigan. The program made 7 awards worth $3.9 million in that time.

Similar open grants